Literature DB >> 9776496

Usefulness of the QTc interval in predicting acute allograft rejection.

B M Richartz1, B Radovancevic, M T Bologna, O H Frazier.   

Abstract

BACKGROUND: Endomyocardial biopsy (EMB) is the gold standard for detecting cardiac allograft rejection. However, EMB is invasive, costly, and unsuitable for frequent monitoring. Recent studies have shown that acute allograft rejection causes ventricular conduction disturbances. Therefore we tested the hypothesis that the electrocardiographic QTc interval correlates with the histopathologic degree of allograft rejection.
METHODS: Between January 1994 and April 1997, 65 adult cardiac allograft recipients (mean age 52.1 +/- 1.7 years) were studied from transplantation until hospital discharge. During EMB, a 12-lead electrocardiogram was obtained. In grading acute allograft rejection, we used both the Texas Heart Institute (THI) scale and the International Society for Heart and Lung Transplantation (ISHLT) scale. 212 paired biopsy specimens and QTc intervals (mean 3.3 per patient) were obtained. We considered an increase of more than 10% of the QTc interval a rejection.
RESULTS: Of the biopsy specimens 177 showed no or mild rejection (THI grade 0-5; ISHLT grade O-IIIA), and 35 showed moderate to severe rejection (THI grade 6-10; ISHLT IIIA-IV). The mean QTc interval was 449 +/- 2 msec for the first group and 517 +/- 11 msec for the second group (p = 0.0001). The correlation between the biopsy grades and the percentage of the changes in the QTc interval was r = 0.73 (p = 0.001). The QTc interval had a sensitivity of 86% (30/ 35) in predicting rejection and a specificity of 88% (1551177) in predicting the absence of rejection.
CONCLUSIONS: Determination of the QTc interval is an accurate, noninvasive means of detecting acute cardiac rejection. Adoption of QTc testing may allow EMB to be used less frequently and more selectively.

Entities:  

Mesh:

Year:  1998        PMID: 9776496     DOI: 10.1055/s-2007-1010228

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  2 in total

1.  Remote noninvasive allograft rejection monitoring for heart transplant recipients: study protocol for the novel evaluation with home electrocardiogram and remote transmission (NEW HEART) study.

Authors:  Lynn V Doering; Kathleen Hickey; David Pickham; Belinda Chen; Barbara J Drew
Journal:  BMC Cardiovasc Disord       Date:  2012-03-02       Impact factor: 2.298

2.  Long QT interval as a marker in acute graft rejection in heart transplant: A case report.

Authors:  Cristhian F Ramirez-Ramos; Diego A Echeverri-Marin; Clara I Saldarriaga-Giraldo; Juan D Ramirez-Barrera; Juan F Agudelo-Uribe; Ricardo Fernandez-Ruiz; Alvaro Quintero
Journal:  Arch Cardiol Mex       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.